An insight on the leading HIV entry inhibitors.

Recent patents on anti-infective drug discovery

Volumn 1, Issue 1, 2006, Pages 67-73

  Veiga, Ana Salomé ^a   Santos, Nuno C ^a   Castanho, Miguel A R B ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ENFUVIRTIDE; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; PEPTIDE FRAGMENT; PEPTIDE T1249; UNCLASSIFIED DRUG;

ANIMAL; CLINICAL TRIAL; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PATENT; REVIEW; VIRUS ENTRY;

ANIMALS; CLINICAL TRIALS AS TOPIC; HIV ENVELOPE PROTEIN GP41; HIV FUSION INHIBITORS; HIV-1; HUMANS; PATENTS AS TOPIC; PEPTIDE FRAGMENTS; VIRUS INTERNALIZATION;

EID: 39049093808     PISSN: 1574891X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489106775244046     Document Type: Review

References (84)